|
|
| | Bortezomib Impurity 9 Basic information |
| Product Name: | Bortezomib Impurity 9 | | Synonyms: | Bortezomib Impurity 9;Bortezomib USP IMP O;WXSBJLWLFBBGKF-LSQMVHIFSA-N;(R)-3-methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butylboronic acid;Bortezomib USP Impurity O;L-Phenylalaninamide, N-(2-pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-;N-(2-pyrazinecarbonyl)-L-phenylalanine-L-phenylalanine-L-leucineboronicacid;Bortezomib L-Phenylalanyl Analog | | CAS: | 1194235-41-0 | | MF: | C28H34BN5O5 | | MW: | 531.41 | | EINECS: | | | Product Categories: | | | Mol File: | 1194235-41-0.mol |  |
| | Bortezomib Impurity 9 Chemical Properties |
| density | 1.227±0.06 g/cm3(Predicted) | | pka | 9.69±0.43(Predicted) |
| | Bortezomib Impurity 9 Usage And Synthesis |
| Uses | N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-L-phenylalaninamide is an impurity of Bortezomib (B675700) and a tripeptide boronic acid proteasome inhibitor used as an antitumor agent. |
| | Bortezomib Impurity 9 Preparation Products And Raw materials |
|
|
Tag:Bortezomib Impurity 9(1194235-41-0)
Related Product Information
|
|
Isovaleraldehyde
Bortezomib Impurity 8
4,6-Methano-1,3,2-benzodioxaborole,2-[(1S)-1-chloro-3-Methylbutyl]hexahydro-3a,5,5-triMethyl-,(3aS,4S,6S,7aR)-
Bortezomib Impurity 57
(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate
(R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanoic acid
BORTEZOMIB-PINANEDIOL
Bortezomib intermediates II
3,6-Dibenzylhexahydropyrazine-2,5-dione
Bortezomib Impurity 52
Desisobutyl-n-butyl BortezoMib
(IS,2S,3R,5S)-Pinanediol-L-phenylalanine-L-leucine boronate, HCl salt
(S,E)-N-(1-((3-methylbut-1-en-1-yl)amino)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide
Bortezomib Impurity 32
(S)-(+)-PINANEDIOL (DICHLORMETHYL)BORONATE
Bortezomib Impurity 47 HCl
Bortezomib Impurity 60
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine
|